Related Experiment Videos
Juvenile scleroderma: report of a case
1Department of Pediatrics, Mackay Memorial Hospital, Taipei, Taiwan R.O.C.
Summary
Juvenile linear scleroderma, a rare childhood connective tissue disease, presented in a 12-year-old boy with leg skin tightening. Treatment with oral prednisolone, D-penicillamine, and emollients proved successful.
Area of Science:
- Dermatology
- Rheumatology
- Pediatrics
Background:
- Scleroderma is a rare autoimmune connective tissue disease.
- Juvenile localized scleroderma encompasses several subtypes, including linear scleroderma.
- Early diagnosis and management are crucial for preventing long-term sequelae in children.
Observation:
- A 12-year-old boy presented with a 3-month history of progressive skin tightening and erythema on his left leg.
- The condition caused limited range of motion in the first and second metatarsophalangeal joints.
- Histopathology revealed hypertrophic collagen bundles, atrophic skin appendages, and lymphocytic infiltration.
Findings:
- The clinical presentation and histopathological findings were consistent with a diagnosis of juvenile linear scleroderma.
- The patient exhibited characteristic skin changes and functional limitations associated with the disease.
Implications:
- This case highlights the importance of recognizing juvenile linear scleroderma in pediatric patients with unexplained skin changes.
- Successful treatment with a combination of systemic corticosteroids, D-penicillamine, and topical emollients suggests a viable therapeutic approach.
- Prompt intervention may help mitigate functional impairment and improve outcomes in affected children.